Skip to content
Dabur India logo

Dabur India

DABUR NSE
₹395.00 No trade today
P/E
35.52
View as Markdown
MCP
Close 4 Nov 2026 ₹395.00 −128.70 −24.6% 1Y
Start ₹523.70

Key Fundamentals

MidcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
20.30%
Debt to Equity
0.11
EPS (TTM)
₹11.12
Book Value
₹64.37
Market Cap
—
P/E (TTM)
35.52
P/B
6.14
ROE
17.00%
Dividend Yield
2.16%
EBITDA
₹3,052 Cr
52W High
₹534.00
52W Low
₹354.30
Volume
0

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Personal Care

Dabur India peer comparison
Godrej Consumer Products
₹849.0045.38₹86,648 Cr6.891.82%16.10%18.80%₹15,949 Cr₹1,914 Cr
Dabur India (this company)
₹395.0035.52₹69,681 Cr6.142.16%17.00%20.30%₹13,552 Cr₹1,947 Cr
Colgate Palmolive
₹1,660.7033.17₹45,422 Cr27.921.47%82.70%108.00%₹6,391 Cr₹1,362 Cr
Cupid
₹336.50329.90₹44,683 Cr100.451.48%27.60%33.90%₹484 Cr₹137 Cr
Gillette
₹7,527.0036.71₹23,745 Cr25.923.32%66.50%90.70%₹3,176 Cr₹668 Cr
P&G Hygiene and Health Care
₹6,959.0028.57₹22,555 Cr29.983.61%115.00%157.00%₹4,245 Cr₹790 Cr
Emami
₹381.3522.24₹16,773 Cr5.692.62%26.20%28.10%₹3,915 Cr₹749 Cr
Median 7 companies₹849.0035.52₹44,683 Cr25.922.16%27.60%33.90%₹4,245 Cr₹790 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

53 Average

Data confidence 100/100

Category scores

Quality
78
Strong
Returns, margins, earnings quality 22% weight
Valuation
38
Weak
Cheap vs sector & own history 24% weight
Growth
46
Average
Sales & profit trajectory 9% weight
Financial Health
84
Strong
Solvency, leverage, coverage 9% weight
Momentum
33
Poor
Trend strength, vol-adjusted 12% weight
Ownership
44
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 70.1%

Weaknesses

1
  • The company has delivered a poor sales growth of 6.65% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish658
OscillatorsNeutral252
Moving AveragesStrong Bullish406

Key readings

RSI (14)
61.32
Neutral
MACD (12,26,9)
−1.70
Bullish
SMA (50)
380.30
Bullish
SMA (200)
435.29
Bearish

As of

Analyst Rating

Based on 37 analysts
BUY59%

22 of 37 analysts rate Buy, 11 Hold, 4 Sell.

As of

BUY
22
59%
HOLD
11
30%
SELL
4
11%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+5.42%
5Y+6.65%
3Y+4.59%
1Y+5.01%
TTM+7.39%

Net profit

Net profit growth by window
10Y+4.07%
5Y+1.97%
3Y+3.19%
1Y+7.41%
TTM+10.94%

Operating cash flow

Operating cash flow growth by window
10Y+8.07%
5Y+4.05%
3Y+20.12%
1Y+29.79%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−0.94 pp
5Y−2.37 pp
3Y−0.18 pp
1Y+0.13 pp
TTM+0.16 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹7,614 Cr
Mar 2018₹7,722 Cr
Mar 2019₹8,515 Cr
Mar 2020₹8,685 Cr
Mar 2021₹9,562 Cr
Mar 2022₹10,889 Cr
Mar 2023₹11,530 Cr
Mar 2024₹12,404 Cr
Mar 2025₹12,563 Cr
Mar 2026₹13,193 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1,280 Cr
Mar 2018₹1,358 Cr
Mar 2019₹1,446 Cr
Mar 2020₹1,448 Cr
Mar 2021₹1,695 Cr
Mar 2022₹1,742 Cr
Mar 2023₹1,701 Cr
Mar 2024₹1,811 Cr
Mar 2025₹1,740 Cr
Mar 2026₹1,869 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹642 Cr −29.7% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 3 Nov 2026
AI opinion · based on fundamentals
Risk medium

Dabur India Ltd trades at ₹381.65 as of 2026-11-03 with a market cap of ₹67,472 crore, a P/E (TTM) of 34.32, and a debt-to-equity ratio of 0.11. The stock sits roughly 28.5% below its 52-week high of ₹534 and just 7.7% above its 52-week low of ₹354.30, reflecting significant underperformance with a 1-year stock CAGR of -28% against a backdrop of modest single-digit revenue and profit growth over the medium term.

Bull Case 8
  • Near-zero leverage: debt-to-equity stands at just 0.11, providing substantial financial flexibility and a strong balance sheet to weather downturns or fund growth initiatives.
  • Healthy dividend payout of 70.1% with a current dividend yield of 2.21%, offering meaningful income return to shareholders relative to the broader FMCG sector.
  • ROCE of 20.96% indicates efficient capital deployment and the ability to generate solid returns on invested capital.
  • TTM profit growth has accelerated to 11%, a noticeable improvement over the 3-year (4%) and 5-year (2%) compounded profit growth rates, suggesting a potential earnings recovery.
  • TTM sales growth of 7% is in line with the 5-year compounded sales growth of 7%, showing consistency in top-line momentum at recent run rates.
  • 10-year average ROE of 21% demonstrates a long track record of generating above-average equity returns, even though recent years have seen some moderation.
  • Trading roughly 28.5% below its 52-week high of ₹534, the stock's valuation compression may reflect much of the negative sentiment already being priced in.
  • P/B ratio of 5.93 combined with an ROE of 15.83% reflects continued brand value and asset-light characteristics typical of established consumer goods franchises.
Bear Case 8
  • The stock has delivered a 1-year CAGR of -28% and a 5-year CAGR of -9%, indicating sustained and severe destruction of shareholder value over multiple time horizons.
  • Compounded profit growth over 5 years is only 2%, significantly lagging inflation and indicating near-stagnant real earnings growth over a meaningful period.
  • Poor sales growth of 6.65% over the past five years points to structural challenges in scaling volumes or pricing power in competitive consumer goods categories.
  • P/E (TTM) of 34.32 remains elevated for a company delivering only 4% compounded profit growth over 3 years and 5% compounded sales growth over 3 years, suggesting the valuation leaves limited margin for error.
  • ROE has trended down from a 10-year average of 21% to 17% last year and 15.83% currently, reflecting a deteriorating return profile.
  • 10-year stock CAGR of just 3% shows the company has failed to create meaningful long-term wealth for shareholders over a full market cycle.
  • 3-year compounded sales growth of 5% and profit growth of 4% suggest the recent TTM improvement to 7% and 11% respectively may not yet represent a durable trend.
  • Even the 10-year compounded profit growth of 4% lags the 10-year sales growth of 5%, implying margin pressure or operating deleverage over the long term.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

9h ago

TL;DR: Dabur is showing clear topline acceleration with Q2FY27 revenue growth of 11.8% YoY, driven by a four-year high in India FMCG and strong hair care and foods performance. The key risk is margin compression, with gross margins expected down 344 bps YoY to 46% due to input cost inflation, though calibrated price hikes are partially offsetting this. The stock's 25% decline over the past year has brought valuations to attractive levels per analysts. The trend is improving on volume and revenue growth, but margin recovery remains the critical variable to watch in coming quarters.

Headwinds 4
  • Gross margin contraction 344bps YoY Oct 12

    Gross margin expected to decrease 344 basis points YoY to 46% in Q2FY27, with operating profit margin falling 62 bps YoY to 17.8% due to elevated inflation in HPC and OTC & Ethicals segments.

  • Health supplements packaging drag Oct 12

    Health supplements impacted by transition to refreshed packaging/labels, expected to record flat to low-single-digit decline in Q2FY27.

  • Stock down ~25% in one year Oct 12

    Dabur stock has lost about a quarter of its value over the last year and trades more than two standard deviations below its medium-term average.

Positives 5
  • Q2FY27 revenue growth accelerates to 11.8% Oct 12

    Revenue growth expected at 11.8% YoY in Q2FY27, up from 10.6% in Q1FY27 and 5.4% in Q2FY26, with India FMCG business hitting a four-year high of 10% YoY growth.

  • Hair care in high teens growth Oct 12

    Hair oils and shampoos registered high teens growth with perfumed/coconut hair oil sales in double digits for the fourth consecutive quarter.

  • Domestic volume growth improving Oct 12

    Domestic volumes projected to grow 5-6% YoY in Q2FY27, up from up to 5% in Q1FY27 and 2% in Q2FY26, showing consistent sequential improvement.

Neutral 2
  • EY appointed joint internal auditor Nov 4

    Ernst & Young LLP appointed as joint internal auditor effective November 4, 2026 until March 31, 2028, serving alongside existing auditor PricewaterhouseCoopers Services LLP.

  • Oral care mid-single-digit growth Oct 12

    Oral care expected to post mid-single-digit growth on a high base, while home care projected at high-single-digit growth in Q2FY27.

Quarterly Results

₹ Cr
DABUR quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3,130
3,204
3,255
2,815
3,349
3,029
3,355
2,830
3,405
3,191
3,559
3,038
3,764
Expenses
2,526
2,543
2,588
2,348
2,694
2,476
2,673
2,403
2,737
2,603
2,825
2,577
3,024
Operating Profit
605
661
667
466
655
553
682
427
667
588
734
461
741
OPM %
19%
21%
20%
17%
20%
18%
20%
15%
20%
18%
21%
15%
20%
Other Income
110
116
127
129
129
152
128
141
144
140
126
175
173
Interest
24
28
36
35
33
47
44
39
35
40
31
40
37
Depreciation
97
98
97
107
109
111
109
117
114
115
117
122
121
PBT
594
651
662
453
643
546
657
412
663
573
711
475
756
Tax %
23%
22%
23%
25%
23%
24%
22%
24%
23%
22%
22%
24%
22%
Net Profit
457
507
506
341
494
418
516
313
508
445
554
362
586
EPS (₹)
2.62
2.91
2.9
1.97
2.82
2.4
2.95
1.81
2.9
2.55
3.16
2.08
3.33

Profit & Loss

₹ Cr
DABUR profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7,795
7,780
7,614
7,722
8,515
8,685
9,562
10,889
11,530
12,404
12,563
13,193
13,552
Expenses
6,475
6,261
6,102
6,104
6,775
6,892
7,560
8,637
9,367
10,004
10,247
10,743
11,029
Operating Profit
1,320
1,518
1,512
1,617
1,740
1,792
2,002
2,252
2,162
2,400
2,316
2,450
2,524
OPM %
17%
20%
20%
21%
20%
21%
21%
21%
19%
19%
18%
19%
19%
Other Income
154
217
296
291
222
205
325
308
445
482
550
585
613
Interest
40
48
54
53
60
50
31
39
78
124
164
145
147
Depreciation
115
133
143
162
177
220
240
253
311
399
446
469
476
PBT
1,319
1,554
1,611
1,693
1,725
1,728
2,056
2,269
2,219
2,359
2,257
2,422
2,513
Tax %
19%
19%
21%
20%
16%
16%
18%
23%
23%
23%
23%
23%
—
Net Profit
1,068
1,254
1,280
1,358
1,446
1,448
1,695
1,742
1,701
1,811
1,740
1,869
1,947
EPS (₹)
6.07
7.11
7.25
7.69
8.17
8.18
9.58
9.84
9.64
10.4
9.97
10.68
11.12
Div. Payout %
33%
32%
31%
81%
34%
37%
50%
53%
54%
53%
80%
77%
—

Balance Sheet

₹ Cr
DABUR balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
176
176
176
176
177
177
177
177
177
177
177
177
Reserves
3,178
3,995
4,671
5,530
5,455
6,429
7,487
8,205
8,796
9,689
10,623
11,242
Borrowings
734
805
975
938
699
522
509
1,030
1,174
1,365
950
1,287
Other Liabilities
2,019
1,956
1,910
2,058
2,106
2,209
2,661
2,872
3,505
3,885
4,479
4,773
Total Liabilities
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480
Fixed Assets
1,877
1,667
1,958
2,028
1,969
2,253
2,243
2,308
3,579
3,815
3,990
3,938
CWIP
50
45
42
42
64
147
147
168
175
232
169
139
Investments
1,813
2,691
3,240
3,805
3,359
2,800
4,160
6,220
6,265
6,933
7,468
8,947
Other Assets
2,365
2,529
2,492
2,827
3,045
4,137
4,283
3,589
3,633
4,136
4,603
4,456
Total Assets
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480

Cash Flow

₹ Cr
DABUR cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,047
1,187
1,227
1,092
1,499
1,614
2,115
1,802
1,488
2,013
1,987
2,579
Investing
−876
−730
−807
−541
338
−517
−1,404
−1,273
−583
−971
−448
−1,279
Financing
−417
−374
−339
−577
−1,888
−1,043
−613
−490
−1,035
−1,161
−1,405
−1,236
Net Cash Flow
−245
82
81
−27
−51
54
97
38
−130
−119
133
64
Free Cash Flow
796
998
741
891
1,274
1,213
1,808
1,433
1,003
1,453
1,448
2,180
CFO/EBITDA
97
97
102
88
106
107
122
97
92
104
103
122

Ratios

DABUR financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
33
38
31
33
36
34
21
22
27
26
26
20
Inventory Days
136
150
153
169
154
164
178
169
158
149
175
166
Days Payable
153
182
181
190
172
176
197
178
171
186
215
212
Cash Conversion Cycle
16
6
3
13
17
22
3
12
14
−10
−14
−26
Working Capital Days
−17
0
−7
−1
−5
9
−9
−14
−13
−17
−13
−42
ROCE %
36%
35%
31%
28%
28%
28%
27%
27%
23%
22%
20%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dabur India insights

74 extracted metrics across FY07–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 66.25%
  • DIIs 18.35%
  • FIIs 9.61%
  • Public 4.65%
  • Others 1.14%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Dabur India

What does Dabur India Ltd do?
Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world.
Where is Dabur India Ltd (DABUR) listed?
Dabur India Ltd trades as DABUR on the NSE and under code 500096 on the BSE.
Which sector does Dabur India Ltd belong to?
Dabur India Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the PE ratio of Dabur India Ltd?
Dabur India Ltd trades at a PE ratio of 35.52 as of 4 Nov 2026, on earnings per share of ₹11.12, against a book value of ₹64.37 per share.
What is the 52-week high and low of Dabur India Ltd?
Over the last 52 weeks Dabur India Ltd has traded between ₹354.3 and ₹534 as of 4 Nov 2026.
Does Dabur India Ltd pay dividends?
Dabur India Ltd has a dividend yield of 2.16%.
What is the Return on Equity (ROE) of Dabur India Ltd?
Dabur India Ltd reported a return on equity of 17.00%. Its debt-to-equity ratio is 0.11.

Company Information

Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world.

Website dabur.com
CEO Mr. Mohit Malhotra M.B.A.
Employees 5,341
Listed 28 Apr 1999
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DABUR.md for Dabur India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Personal Care stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month